Stryker Free Cash Flow 2010-2025 | SYK
Stryker annual/quarterly free cash flow history and growth rate from 2010 to 2025. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Stryker free cash flow for the quarter ending March 31, 2025 was 3,487.00, a year-over-year.
- Stryker free cash flow for the twelve months ending March 31, 2025 was , a year-over-year.
- Stryker annual free cash flow for 2024 was $3.487B, a 11.19% increase from 2023.
- Stryker annual free cash flow for 2023 was $3.136B, a 54.03% increase from 2022.
- Stryker annual free cash flow for 2022 was $2.036B, a 25.64% decline from 2021.
| Stryker Annual Free Cash Flow |
| 2024 |
3,487.00 |
| 2023 |
3,136.00 |
| 2022 |
2,036.00 |
| 2021 |
2,738.00 |
| 2020 |
2,790.00 |
| 2019 |
1,542.00 |
| 2018 |
2,038.00 |
| 2017 |
961.00 |
| 2016 |
1,425.00 |
| 2015 |
711.00 |
| 2014 |
1,549.00 |
| 2013 |
1,691.00 |
| 2012 |
1,447.00 |
| 2011 |
1,275.00 |
| 2010 |
1,426.00 |
| 2009 |
1,331.00 |
| Stryker Quarterly Free Cash Flow |
| 2024-12-31 |
3,487.00 |
| 2024-09-30 |
1,822.00 |
| 2024-06-30 |
518.00 |
| 2024-03-31 |
37.00 |
| 2023-12-31 |
3,136.00 |
| 2023-09-30 |
1,753.00 |
| 2023-06-30 |
851.00 |
| 2023-03-31 |
315.00 |
| 2022-12-31 |
2,036.00 |
| 2022-09-30 |
1,221.00 |
| 2022-06-30 |
470.00 |
| 2022-03-31 |
84.00 |
| 2021-12-31 |
2,738.00 |
| 2021-09-30 |
1,944.00 |
| 2021-06-30 |
1,141.00 |
| 2021-03-31 |
369.00 |
| 2020-12-31 |
2,790.00 |
| 2020-09-30 |
1,718.00 |
| 2020-06-30 |
958.00 |
| 2020-03-31 |
447.00 |
| 2019-12-31 |
1,542.00 |
| 2019-09-30 |
1,006.00 |
| 2019-06-30 |
540.00 |
| 2019-03-31 |
191.00 |
| 2018-12-31 |
2,038.00 |
| 2018-09-30 |
1,146.00 |
| 2018-06-30 |
668.00 |
| 2018-03-31 |
176.00 |
| 2017-12-31 |
961.00 |
| 2017-09-30 |
468.00 |
| 2017-06-30 |
531.00 |
| 2017-03-31 |
12.00 |
| 2016-12-31 |
1,425.00 |
| 2016-09-30 |
1,679.00 |
| 2016-06-30 |
526.00 |
| 2016-03-31 |
147.00 |
| 2015-12-31 |
711.00 |
| 2015-09-30 |
37.00 |
| 2015-06-30 |
623.00 |
| 2015-03-31 |
334.00 |
| 2014-12-31 |
1,549.00 |
| 2014-09-30 |
931.00 |
| 2014-06-30 |
455.00 |
| 2014-03-31 |
139.00 |
| 2013-12-31 |
1,691.00 |
| 2013-09-30 |
1,075.00 |
| 2013-06-30 |
496.00 |
| 2013-03-31 |
187.00 |
| 2012-12-31 |
1,447.00 |
| 2012-09-30 |
900.00 |
| 2012-06-30 |
389.00 |
| 2012-03-31 |
-17.00 |
| 2011-12-31 |
1,275.00 |
| 2011-09-30 |
712.00 |
| 2011-06-30 |
322.00 |
| 2011-03-31 |
209.00 |
| 2010-12-31 |
1,426.00 |
| 2010-09-30 |
957.00 |
| 2010-06-30 |
533.20 |
| 2010-03-31 |
243.70 |
| 2009-12-31 |
1,331.00 |
| 2009-09-30 |
832.50 |
| 2009-06-30 |
152.20 |
| 2009-03-31 |
242.50 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$144.362B |
$22.595B |
|
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
|
